Four-year minimum follow-up of ongoing patients (pts) with chronic-phase chronic myeloid leukemia (CP-CML) in a phase 1 trial of ponatinib (PON) Meeting Abstract


Authors: Talpaz, M.; Cortes, J. E.; Kantarjian, H. M.; Shah, N. P.; Bixby, D. L.; Flinn, I.; O'Hare, T. J.; Hu, S. M.; Rivera, V. M.; Clackson, T. P.; Conlan, M. G.; Haluska, F. G.; Druker, B. J.; Deininger, M. W. N.; Mauro, M. J.
Abstract Title: Four-year minimum follow-up of ongoing patients (pts) with chronic-phase chronic myeloid leukemia (CP-CML) in a phase 1 trial of ponatinib (PON)
Meeting Title: 2015 Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 33
Issue: 15 Suppl.
Meeting Dates: 2015 May 29-Jun 2
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2015-05-20
Language: English
ACCESSION: WOS:000358036901583
PROVIDER: wos
Notes: Meeting Abstract: 7047 -- Source: Wos